1
|
Mazzeffi M, Miller D, Garneau A, Sheeran J, Kleiman A, Mehta SH, Tiouririne M. Cesarean Delivery Outcomes for Patients with Coronavirus Disease-2019 in the USA. J Racial Ethn Health Disparities 2023:10.1007/s40615-023-01857-2. [PMID: 37938434 DOI: 10.1007/s40615-023-01857-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Revised: 10/25/2023] [Accepted: 10/27/2023] [Indexed: 11/09/2023]
Abstract
INTRODUCTION Coronavirus disease-2019 (COVID-19) may have increased morbidity and mortality in patients having Cesarean delivery (CD) in the USA. METHODS We performed a retrospective cohort study of patients who had CD in 2020 using the national inpatient sample. After stratification by COVID-19 status, demographics, comorbidities, complications, mortality, and costs were compared. RESULTS There were 31,444,222 hospitalizations in the USA in 2020 with a mortality rate of 2.8%. Among these, 1,453,945 patients had COVID-19 and mortality was 13.2%. There were 1,108,755 patients who had CD and 15,550 had COVID-19. Patients with COVID-19 more frequently had Medicaid and were Hispanic. Patients with COVID-19 had more comorbidities including chronic hypertension, diabetes mellitus, pre-eclampsia, and eclampsia. Mortality in CD patients with COVID-19 was 30 in 10,000 patients, while for non-COVID-19 patients, it was 1 in 10,000 patients, P < 0.001. The crude odds ratio for mortality in COVID-19 patients was 32.1 (95% confidence interval = 22.9 to 44.7), P < 0.001 and the adjusted odds ratio was 29.3 (95% confidence interval = 20.7 to 41.4), P < 0.001. CONCLUSIONS CD patients with COVID-19 had 30-fold higher mortality before widespread vaccination was available with Hispanic and Medicaid patients disproportionately impacted. Potential explanations for this disparity include reduced access to personal protective equipment (e.g., masks) and testing, as well as socio-economic factors. Further research is needed to understand the factors that contributed to disparities in infection and clinical outcomes among obstetric patients during the COVID-19 pandemic. In future pandemics, enhanced efforts will be needed to protect economically disadvantaged women who are pregnant.
Collapse
Affiliation(s)
- Michael Mazzeffi
- Department of Anesthesiology, University of Virginia Health, PO Box 800710, Charlottesville, VA, 22908, USA.
| | - David Miller
- University of Virginia School of Medicine, Charlottesville, VA, USA
| | - Ashley Garneau
- Department of Anesthesiology, University of Virginia Health, PO Box 800710, Charlottesville, VA, 22908, USA
| | - Jessica Sheeran
- Department of Anesthesiology, University of Virginia Health, PO Box 800710, Charlottesville, VA, 22908, USA
| | - Amanda Kleiman
- Department of Anesthesiology, University of Virginia Health, PO Box 800710, Charlottesville, VA, 22908, USA
| | - Sachin H Mehta
- Department of Anesthesiology, University of Virginia Health, PO Box 800710, Charlottesville, VA, 22908, USA
| | - Mohamed Tiouririne
- Department of Anesthesiology, University of Virginia Health, PO Box 800710, Charlottesville, VA, 22908, USA
| |
Collapse
|
2
|
Cannarella R, Kaiyal RS, Marino M, La Vignera S, Calogero AE. Impact of COVID-19 on Fetal Outcomes in Pregnant Women: A Systematic Review and Meta-Analysis. J Pers Med 2023; 13:1337. [PMID: 37763105 PMCID: PMC10533032 DOI: 10.3390/jpm13091337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2023] [Revised: 08/24/2023] [Accepted: 08/29/2023] [Indexed: 09/29/2023] Open
Abstract
Background: Coronavirus disease (COVID-19) is a pandemic causing respiratory symptoms, taste alterations, olfactory disturbances, and cutaneous, cardiovascular, and neurological manifestations. Recently, research interest has shifted to reproductive health to understand the factors predisposing to COVID-19 infection in pregnancy, the consequences of the infection on the fetus and on the mother, and possible vertical transmission through the placenta. Pregnancy does not increase the risk of SARS-CoV-2 infection, according to studies. However, contrary to non-pregnant women, pregnancy worsens the clinical outcome of COVID-19. Studies investigating the effects of COVID-19 on pregnancy women are heterogeneous, and the results are often conflicting. Objectives: The goal of the current work was to offer a thorough and up-to-date systematic review of, and meta-analysis on, the impact of COVID-19 on ovarian function, pregnancy, and fetal outcomes. Search strategy: This meta-analysis (PROSPERO n. CRD42023456904) was conducted using the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) protocols. The search for relevant material was conducted using PubMed, Scopus, Cochrane, and Embase databases, through to 15 December 2022. Selection criteria: Original articles on fertile pregnant women or women attempting to become pregnant, with an active case of, or history of, SARS-CoV-2 infection were included, and reproductive function was compared to that of uninfected women. Data collection and analysis: The effects of COVID-19 on female reproductive function, particularly ovarian function, the profile of female sex hormones, pregnancy outcomes and fetal outcomes were the focus of our search. Quantitative analysis was performed with Comprehensive Meta-Analysis Software. The standard difference of the mean was calculated for the statistical comparison between cases and controls. Cochran's Q test and heterogeneity (I2) indexes were used to assess statistical heterogeneity. Sensitivity analysis and publication bias tests were also performed. Main Results: Twenty-eight articles met our inclusion criteria, for a total of 27,383 patients pregnant or looking to have offspring, with active or anamnestic COVID-19, and 1,583,772 uninfected control women. Our study revealed that there was no significant difference between COVID-19 patients and the control group in terms of maternal characteristics such as age, body mass index (BMI) and comorbidities that could affect pregnancy and fetal outcomes. The risk of a miscarriage or Cesarean delivery was significantly lower, while the risk of fetal death or premature delivery was significantly higher in COVID-19 patients than in the controls. None of the included studies evaluated hormonal profiles or investigated the presence of infertility. Conclusions: Maternal comorbidities, age, and BMI do not raise the risk of COVID-19. However, pregnant women with COVID-19 had a lower risk of miscarriage and Cesarean delivery, possibly because of better prenatal care and high levels of observation during labor. COVID-19 during pregnancy increases the risk of fetal death and premature delivery.
Collapse
Affiliation(s)
- Rossella Cannarella
- Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, Italy; (M.M.); (S.L.V.); (A.E.C.)
- Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA;
| | - Raneen Sawaid Kaiyal
- Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA;
| | - Marta Marino
- Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, Italy; (M.M.); (S.L.V.); (A.E.C.)
| | - Sandro La Vignera
- Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, Italy; (M.M.); (S.L.V.); (A.E.C.)
| | - Aldo E. Calogero
- Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, Italy; (M.M.); (S.L.V.); (A.E.C.)
| |
Collapse
|
3
|
Hidalgo-Lopezosa P, Cubero-Luna AM, Huertas-Marín J, Hidalgo-Maestre M, De la Torre-González AJ, Rodríguez-Borrego MA, López-Soto PJ. Vaginal birth after caesarean section before and during COVID-19 pandemic. Factors associated with successful vaginal birth. Women Birth 2021; 35:570-575. [PMID: 34972660 PMCID: PMC8702403 DOI: 10.1016/j.wombi.2021.12.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2021] [Revised: 11/25/2021] [Accepted: 12/22/2021] [Indexed: 11/16/2022]
Abstract
Background The ratio of caesarean has been increasing considerably in many countries. Planning a vaginal birth after a previous caesarean is considered an important option for women in a subsequent pregnancy. Aims To analyse obstetric and neonatal outcomes in women in labour after caesarean section before and during the COVID-19 pandemic, and to determine factors associated with successful vaginal birth after caesarean (VBAC). Methods Observational cohort study of women in labour with history of caesarean section who gave birth between March 2019 and December 2020 in a tertiary hospital in southern Spain. Consecutive sampling was performed using the maternal birth database and a descriptive and inferential analysis of the study variables was carried out. Socio-demographic, obstetric and neonatal variables were compared between the pre-pandemic and pandemic periods. Multiple logistic regression analysis was performed to determine variables associated with VBAC success. Findings The VBAC success rate was 67.4%. The caesarean section rate was significantly higher during the COVID-19 pandemic period. Factors associated with VBAC success were: birth before the pandemic (OR 0.32) and at night (OR 0.45), use of epidural analgesia (OR 2.14), and having had a previous vaginal birth (OR 1.98). Conclusions The success rate of VBAC was lower during the pandemic. Knowledge of the factors related to VBAC success is critical for practitioners when supporting women in decision-making about mode of birth after a previous caesarean section.
Collapse
Affiliation(s)
- P Hidalgo-Lopezosa
- Maimónides Institut of Biomedic Research of Córdoba (IMIBIC), Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; Department of Nursing, Farmacology and Physiotherapy, University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; University Hospital Reina Sofia, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
| | - A M Cubero-Luna
- Maimónides Institut of Biomedic Research of Córdoba (IMIBIC), Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; Department of Nursing, Farmacology and Physiotherapy, University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; University Hospital Reina Sofia, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
| | - J Huertas-Marín
- Maimónides Institut of Biomedic Research of Córdoba (IMIBIC), Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; Department of Nursing, Farmacology and Physiotherapy, University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; University Hospital Reina Sofia, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
| | - M Hidalgo-Maestre
- Department of Nursing, Farmacology and Physiotherapy, University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; University Hospital Reina Sofia, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
| | - A J De la Torre-González
- Department of Nursing, Farmacology and Physiotherapy, University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; University Hospital Reina Sofia, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
| | - M A Rodríguez-Borrego
- Maimónides Institut of Biomedic Research of Córdoba (IMIBIC), Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; Department of Nursing, Farmacology and Physiotherapy, University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; University Hospital Reina Sofia, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
| | - P J López-Soto
- Maimónides Institut of Biomedic Research of Córdoba (IMIBIC), Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; Department of Nursing, Farmacology and Physiotherapy, University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain; University Hospital Reina Sofia, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
| |
Collapse
|